Valuation
26% of the score
40median 53
Royalty Pharma plc is valued at 29.7x its operating profit, including debt: a rich multiple.
60x
50x
35x
25x
18x
12x
8x
29.7x
Full points at 8x or less, none from 60xfull points
RPRXRoyalty Pharma plc
$63.84+78% 1Y
$63.84
$35.8652 weeks$63.98
RyuScore
Seven criteria, each scored 0 to 100 on a published scale, weighted into one number.
RyuScore 50 out of 100, Average
Today's price. Only valuation depends on it.
Average. Royalty Pharma plc scores higher than 44% of the 2,231 companies Ryufin scores.
Carried by capital allocation and cycle position, held back by valuation and return on new capital.
Healthcare median 19 · all companies 55
How the score has moved
At each fiscal year end, from the reports and price of the time47
29
59
53
56
50
20212022202320242025today
The biggest move was up 30 points from 2022 to 2023, mostly valuation.
Return on capital
18% of the score
46median 24
Over 6 years the business earned 8.2% a year after tax on the capital it uses.
2%
8%
15%
25%
8.2%
None at 2% or less, full points from 25%full points
6 years agolatest 8.7%
Return on new capital
16% of the score
21median 33
Over 6 years yearly profit fell by 1 cents for every dollar earned. New capital earned -3.3%, and 44% of profit went back into the business.
-5%
12%
-1.4%
None at minus 5 cents, full points from 12 centsfull points
Capital allocation
14% of the score
89median 63
How management spends the money: shares bought back or issued, and whether assets grow faster than the business they serve.
Share countDown 3.2% a year over 2 years: buybacks
1005%
-3%
-3.2%
0 pointsfull points
Assets against salesAssets grew 4.1% a year, sales 2.3%
7312%
-2%
1.8%
0 pointsfull points
Cycle position
12% of the score
70median 63
Today's operating margin of 60% is 0.96x its normal 62%: close to its usual level. Normal is half the 8 year median, half the last four years, so a margin that has held is not taken for a peak.
2x
1.5x
1x
0.7x
1x
A trough earns points, a peak costs themfull points
8 years agonow 60%
Balance sheet
8% of the score
13median 50
What the debt weighs against the profit that has to carry it.
Net debt to EBITDA5.4x a year of EBITDA
04.5x
0.5x
5.4x
0 pointsfull points
Interest coverOperating profit covers interest 4x
261.5x
12x
4.2x
0 pointsfull points
Earnings quality
6% of the score
100median 90
Whether the reported profit arrives as cash, and whether the accounts show the usual signs of stretching.
Cash against profitOperating cash flow was 2.98x profit over 3 years
1000.7x
1x
1.3x
3x
0 pointsfull points
AccrualsCash ran ahead of profit by 9.1% of assets
1008%
0%
-8%
-9.1%
0 pointsfull points
How the RyuScore works
Each criterion earns 0 to 100 points on the scale drawn under it, and the RyuScore is their average weighted 26, 18, 16, 14, 12, 8 and 6. Scales bend in the company's favour between their ends, so an ordinary figure is never already near zero. Where a criterion cannot be measured from the filings it is taken out and the remaining weights scale up; a company needs 60% of the weight covered, and always a price, to get a score.
Built from the company's annual and quarterly filings with the SEC and today's share price. Banks, insurers and property trusts are not scored: their debt is their raw material, so these yardsticks mean something else there. Figures as of 2026-06-30, latest annual report FY2025.